Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1323.1000 -17.30 (-1.29%)
NSE Apr 07, 2026 14:30 PM
Volume: 1.2M
 

1323.10
-1.29%
Motilal Oswal
Under the Production-Linked Incentive (PLI) scheme, ARBP constructed the PENG and 6-APA plants within a record three-year period and ramped up production following the start of the PEN-G plant in Jul’25.
Geojit BNP Paribas increased Buy price target of Aurobindo Pharma Ltd. to 1502.0 on 01 Apr, 2026.
More from Aurobindo Pharma Ltd.
Recommended